McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1091.67−13.37 (-1.21%)
Close on Nov 17, 2026Market cap $127.28BP/E 29.2Yield 0.29%
McKesson total assets
Total assets on the balance sheet at the end of each period.
McKesson's total assets was $88.33B at Jun 30, 2026. For fiscal 2026 it was $82.32B, up 9.6% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $82.32B in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $82.32B | +9.6% |
| FY2025 | Mar 31, 2025 | $75.14B | +11.4% |
| FY2024 | Mar 31, 2024 | $67.44B | +8.2% |
| FY2023 | Mar 31, 2023 | $62.32B | -1.5% |
| FY2022 | Mar 31, 2022 | $63.30B | -2.6% |
| FY2021 | Mar 31, 2021 | $65.02B | +6.2% |
| FY2020 | Mar 31, 2020 | $61.25B | +2.6% |
| FY2019 | Mar 31, 2019 | $59.67B | -1.2% |
| FY2018 | Mar 31, 2018 | $60.38B | -1.0% |
| FY2017 | Mar 31, 2017 | $60.97B | +7.9% |
| FY2016 | Mar 31, 2016 | $56.52B | +4.9% |
| FY2015 | Mar 31, 2015 | $53.87B | +4.1% |
| FY2014 | Mar 31, 2014 | $51.76B | +48.8% |
| FY2013 | Mar 31, 2013 | $34.79B | +5.1% |
| FY2012 | Mar 31, 2012 | $33.09B | +7.1% |
| FY2011 | Mar 31, 2011 | $30.89B | +9.6% |
| FY2010 | Mar 31, 2010 | $28.19B | +11.6% |
| FY2009 | Mar 31, 2009 | $25.27B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $88.33B | +8.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $82.32B | +9.6% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $84.19B | +18.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $84.16B | +16.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $81.31B | +13.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $75.14B | +11.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $71.08B | +6.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $72.43B | +9.6% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $71.67B | +11.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $67.44B | +8.2% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $66.51B | +6.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $66.09B | +4.8% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $64.10B | +2.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $62.32B | -1.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $62.69B | -1.6% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $63.08B | -0.8% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $62.30B | -1.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $63.30B | -2.6% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $63.71B | +3.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $63.60B | +3.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $62.89B | +9.1% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $65.02B | +6.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $61.85B | +1.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $61.56B | +4.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $57.67B | -6.5% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $61.25B | +2.6% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $60.87B | -0.2% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $58.99B | -4.0% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $61.68B | +0.6% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $59.67B | -1.2% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $61.01B | -5.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $61.42B | -3.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $61.28B | -0.9% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $60.38B | -1.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $64.21B | +11.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $63.85B | +9.5% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $61.82B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $60.97B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $57.87B | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $58.32B | – |
See a number that looks wrong?